An international comparative study of blood pressure in populations of European vs. African descent
© Cooper et al; licensee BioMed Central Ltd. 2005
Received: 09 August 2004
Accepted: 05 January 2005
Published: 05 January 2005
The consistent finding of higher prevalence of hypertension in US blacks compared to whites has led to speculation that African-origin populations are particularly susceptible to this condition. Large surveys now provide new information on this issue.
Using a standardized analysis strategy we examined prevalence estimates for 8 white and 3 black populations (N = 85,000 participants).
The range in hypertension prevalence was from 27 to 55% for whites and 14 to 44% for blacks.
These data demonstrate that not only is there a wide variation in hypertension prevalence among both racial groups, the rates among blacks are not unusually high when viewed internationally. These data suggest that the impact of environmental factors among both populations may have been under-appreciated.
Population surveys in the US from early in the last century have consistently documented higher blood pressures and related cardiovascular sequelae in blacks compared to whites [1, 2]. The enormous attention focused on this observation has resulted in a dichotomous view of hypertension risk: whereby populations of African origin are considered more susceptible than all other continental groupings and a strong genetic hypothesis of inherent predisposition to hypertension among blacks has become the conventional wisdom [3–5]. Since this research has been limited primarily to the US, the generalizability of these conclusions is open to question. Data on the prevalence of hypertension in other genetically-related populations of African and European descent constitute important evidence but have so far not been considered in the debate.
International comparative studies on hypertension have been seriously limited by the absence of a valid method of standardization. In the last decade, however, high quality population surveys have been conducted in a wide range of populations that used either careful internal standardization or sufficiently comparable methods [6–15]. We report here on the patterns of hypertension prevalence in a sample of 3 such surveys among blacks from Africa, the Caribbean and the US and 8 surveys among whites from the US, Canada and Europe.
Black populations were drawn from the International Collaborative Study on Hypertension (ICSHIB) and the National Health and Nutrition Survey III [6, 16]. A primary report of ICSHIB demonstrated a gradient in hypertension risk from east to west, parallel to the gradient in socioeconomic development and associated lifestyle . An extensive process of cross-standardization was incorporated into ICSHIB to ensure that measurement technique did not bias the survey results . We subsequently identified surveys on hypertension conducted since 1986 that were national in scope in North America and Europe. Two North American and six European surveys were included, viz: US  and Canada, , England , Finland , Germany , Italy , Spain  and Sweden . The US data from NHANES-III are available for public use through the National Center for Health Statistics . Investigators in Canada and Europe were contacted and invited to join this project. More detailed methods for this component of the study were reported earlier . In brief, after achieving consensus on the main goals and resolving the methodological issues, data collection forms were distributed. Each collaborator provided average gender- and age-specific data by 5-year age groups for BPs, body mass index (BMI), and counts of hypertensives by treatment and control status. A description of the key aspects of each survey, including the BP measurement procedure, was collected in a standardized format.
Hypertension Prevalence (%) among Persons 35–64 Years, in African- and European-Origin Populations *
US – Black
US – White
Data collection methods
The examination methods have been reported in detail previously [6, 7, 16]. In brief, the mercury sphygmomanometer was used for BP measurements in every country except England, where the Dinamap 8100 oscillometric device was used. All studies had at least 2 measurements and the 2nd BP from the clinic visit was used to create the mean for the age-gender groups, except for England where the 2nd home BP was used. Hypertension was defined as BP ≥ 140/90 mmHg or current use of antihypertensive medication.
BP, body mass index (BMI), and hypertension prevalence were calculated for 5-year age-gender groups and aggregated as the primary data file. To achieve maximum overlap we restricted the analysis to 35–74 years for age-specific estimates of BP and hypertension prevalence, and 35–64 years for age-adjusted results. In the US NHANES whites and blacks were analyzed separately with the appropriate weighting for population size. As previously reported, the prevalence estimates obtained for US blacks from ICSHIB were virtually identical to those from NHANES ; to enhance generalizability, however, we used the NHANES data to represent the US black population. Hypertension prevalence and control was age-adjusted by age-averaging the 5-year age groups combining the data for men and women. For comparison of all white vs. all black populations the mean BP's and prevalences were averaged, considering each country as a single unit (i.e., without weighting by population size).
Patterns of blood pressure
Mean Systolic and Diastolic Blood Pressure and Body Mass Index among Persons 35–74 Years, in African- and European-Origin Populations*
Total Sys / Dias
Men Sys / Dias
Women Sys / Dias
US – Black
US – White
Hypertension prevalence and obesity
The only etiological factor on which standardized information was available was obesity, measured by its proxy BMI. The correlation between average BMI and hypertension prevalence was 0.6 (p < 0.01), all populations combined. Within the black populations the same correlation was observed between mean BMIs and hypertension prevalence (r = 0.6). Among whites, however, the relationship was weaker (r = 0.3). Of course, since obesity will be correlated with many other aspects of lifestyle, it is difficult to infer whether weight gain itself is playing a less important role in determining the variation among white populations. The contrasts noted above in hypertension prevalence by gender are consistent with the relative excess of obesity in women compared to men among Jamaicans and US blacks [2, 6].
Comparisons of BP distributions across populations are made difficult by the requirement of comparability of the survey methods. In the last two decades, however, adoption of standardized protocols along with rigorous training have greatly improved the quality of epidemiological studies of hypertension [6, 17–19]. A number of countries now conduct recurring national surveys that monitor both secular trends and regional variation within the country [10–12, 19, 20]. While independent surveys from the same base population had given divergent results in the past, at least two recent single-community studies conducted in the US provided estimates virtually identical to NHANES [21, 22]. Although this evidence does not diminish the requirement of careful assessment of survey methodology before making comparisons, it does demonstrate that reliable information can be obtained from independent studies.
The data presented here demonstrate a two-fold variation in prevalence of hypertension in both European- and African-origin populations. The prevalences are similar in blacks in the US and whites in Europe, although important gender differences are apparent. Although not a systematic sample, the populations that are included generally reflect the characteristic social setting in which these groups are found around the world. Summed across all groups, the white populations on average have a substantially higher burden of hypertension. This result can be attributed in large part to the inclusion of several black samples from developing countries where risk factors for hypertension are presently at a lower level. In the only head-to-head comparison within the same survey, US blacks have a prevalence that is 50% higher than among whites. Data from the UK, including the national survey, also demonstrate higher BPs and more hypertension among blacks of Caribbean and African descent [23–27]. On the whole, however, the published literature on racial disparities in hypertension from the UK is less consistent than in the US, where essentially every study has reported higher rates among blacks . Surveys from Cuba, Trinidad and Brazil have also shown a smaller black-white gradient in BP than found in North America [29–31].
Are these findings merely artifactual, reflecting either methodological error or the sampling process? The most unexpected features of the data presented here are the high rates of hypertension in Europe, when contrasted to whites in Canada and the US. These results have been reported in greater detail in an earlier publication . It is beyond the usual standard of statistical significance for the six European surveys to be higher by chance than both of those in North America (p < 0.05). As previously demonstrated, mortality rates for stroke – the most sensitive vital statistics indicator of uncontrolled high BP – are strongly correlated with the prevalence of hypertension among these countries ('r' = 0.8) . Although the data are more limited, hypertension appears to be even more common in Eastern Europe [32–34]. In a comparison of Pol-MONICA with the US-based ARIC study, systolic BPs in Poland were 20 mmHg higher than in the US .
The primary purpose of this analysis was to provide descriptive results and very limited information was available on factors that might explain the findings we observed. The gradient among the black populations is consistent with the transition to an industrialized lifestyle and is thereby collinear with most known risk factors . BMI is serving as an effective proxy for this relationship, although its independent contribution cannot be quantified. The explanation of the European-North American contrasts among the white populations is not as apparent. As we have discussed elsewhere, either known risk factors other than obesity are having a larger impact at the population level than usually appreciated, or unknown factors are at work . In either case, further examination of this question seems justified.
Treatment guidelines and practice patterns vary widely among these countries [16–19]. Widespread treatment could, of course, alter the mean BPs in a population, although this effect would be confined to persons over 55 where hypertension is common. The US has the highest rate of treatment, with about 25% of hypertensives controlled, compared to 10% in Europe and less than 1% in Africa (with hypertension defined as 140/90 mmHg). Any biases that would be introduced into the cross-national comparisons by differential treatment and control are insufficient to alter the primary conclusions, however. The virtual absence of treatment in rural Africa would mean that the natural distribution has essentially been observed unaltered. The effect of treatment in the US or Canada would not be apparent in younger individuals, where contrasts in BPs with Europe and Africa are equally large.
If the North American-European contrasts are occurring in genetically homogeneous populations, large environmental influences must be at work that are not apparent on the surface. A similar process could be taking place across the social environments into which persons of African origin are assorted within societies such as the US and the UK. The debate over inherent susceptibility cannot be resolved with these data since neither the genetic nor the environmental influences can be held constant, allowing a test of the relative influence of the other factor. In fact, the question of inherent susceptibility is probably non-testable under any circumstances [35–37]. While the assumption is often made that contrasting environmental influences between blacks and whites can be adjusted by using proxy measures such as education, that assumption does not hold up under close examination . Perhaps more to the point, however, these data demonstrate that the consistent emphasis given to the genetic elements of the racial contrasts may be a distraction from the more relevant issue of defining and intervening on the preventable causes of hypertension, which are likely to have a similar impact regardless of ethnic and racial background . Once the problem of ethnic/racial contrasts is characterized more closely as a special instance of environmental influences at the population level, it could become more tractable in both the realms of research and practice.
The authors are grateful for the use of the data from the Osservatorio Epidemiologico Cardiovascolare, Italy. We would like to thank Guichan Cao for assistance in data management and analysis at Loyola University. Funding was provided by the Centers for Disease Control and Prevention, USA.
This work was supported by a grant from the Cardiovascular Branch of the US Centers for Disease Control and Prevention, Atlanta, GA (Cooperative agreement 0755).
- Lackland DT, Keil JE: Epidemiology of hypertension in African Americans. Semin Nephrol. 1996, 16: 63-70.PubMedGoogle Scholar
- Cooper R, Rotimi C: Hypertension in blacks. Am J Hypertens. 1997, 10: 804-812. 10.1016/S0895-7061(97)00211-2.View ArticlePubMedGoogle Scholar
- Cooper RS, Rotimi C: Hypertension in populations of West African origin: Is there a genetic predisposition?. J Hypertens. 1994, 12: 215-227.View ArticlePubMedGoogle Scholar
- Brewster LM, Clark JF, van Montfrans GA: Is greater tissue activity of creatine kinase the genetic factor increasing hypertension risk in black people of sub-Saharan African descent?. J Hypertens. 2000, 18: 1537-1544. 10.1097/00004872-200018110-00002.View ArticlePubMedGoogle Scholar
- Grim CE, Robinson M: Blood pressure variation in blacks: genetic factors. Semin Nephrol. 1996, 16: 83-93.PubMedGoogle Scholar
- Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, Muna W, Kingue S, Fraser H, Forrester T, Bennett F, Wilks R: Hypertension prevalence in seven populations of African origin. Am J Public Health. 1997, 87: 160-168.View ArticlePubMedPubMed CentralGoogle Scholar
- Ataman SL, Cooper R, Rotimi C, McGee D, Osotimehin B, Kadiri S, Kingue S, Muna W, Fraser H, Forrester T, Wilks R: Standardization of blood pressure measurement in an international comparative study. J Clin Epidemiol. 1996, 49: 869-877. 10.1016/0895-4356(96)00111-4.View ArticlePubMedGoogle Scholar
- Burt VL, Whelton P, Roccella EL, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995, 25: 305-313.View ArticlePubMedGoogle Scholar
- Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P: Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997, 10: 1097-1102. 10.1016/S0895-7061(97)00224-0.View ArticlePubMedGoogle Scholar
- Primatesta P, Brooks M, Poulter NR: Improved hypertension management and control: results from the Health Survey for England 1998. Hypertension. 2001, 38: 827-832.PubMedGoogle Scholar
- Kastarinen MJ, Salomaa VV, Vartiainen EA, Jousilahti PJ, Tuomilehto JO, Puska PM, Nissinen AM: Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens. 1998, 16: 1379-1387. 10.1097/00004872-199816090-00019.View ArticlePubMedGoogle Scholar
- Thamm M: Blood pressure in Germany – current status and trends. Gesundheitswesen. 1999, 61: S90-S93.PubMedGoogle Scholar
- Giampaoli S, Palmieri L, Dima F, Pilotto L, Vescio MF, Vanuzzo D: Socioeconomic aspects and cardiovascular risk factors: experience at the Cardiovascular Epidemiologic Observatory. Ital Heart J Suppl. 2001, 2: 294-302.PubMedGoogle Scholar
- Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillon P, del Rey Calero J: Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension. 1998, 32: 998-1002.View ArticlePubMedGoogle Scholar
- Stegmayr B, Harmsen P, Rajakangas AM, Rastenyte D, Sarti C, Thorvaldsen P, Tuomilehto J: Stroke around the Baltic Sea: Incidence, case fatality and population risk factors in Denmark, Finland, Sweden and Lithuania. Cerebrovasc Dis. 1996, 6: 80-88.View ArticleGoogle Scholar
- Wolf-Maier K, Cooper RS, Banegas JR, Biampaoli S, Hense H, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension and blood pressure level in six European countries, Canada and the US. JAMA. 2003, 289: 2363-2369. 10.1001/jama.289.18.2363.View ArticlePubMedGoogle Scholar
- The WHO MONICA Project. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35–64 years. World Health Stat Q. 1988, 41: 115-140.
- Wolf HK, Tuomilehto J, Kuulasmaa K, Domarkiene S, Cepaitis Z, Molarius A, Sans S, Dobson A, Keil U, Rywik S: Blood pressure levels in the 41 populations of the WHO MONICA Project. J Hum Hypertens. 1997, 11: 733-742. 10.1038/sj.jhh.1000531.View ArticlePubMedGoogle Scholar
- Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1995, 26: 60-69.View ArticlePubMedGoogle Scholar
- Hajjar I, Kotchen T: Regional variations of blood pressure in the United States are associated with regional variations in dietary intakes: The NHANES-III data. J Nutr. 2003, 133: 211-214.PubMedGoogle Scholar
- Freeman V, Rotimi C, Cooper R: Hypertension prevalence, awareness, treatment, and control among African Americans in the 1990s: Estimates from the Maywood Cardiovascular Survey. Am J Prev Med. 1996, 12: 177-185.PubMedGoogle Scholar
- Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, Basit M, Cooper RS, Iannacchione VG, Visscher WA, Staab JM, Hobbs HH, Dallas Heart Study Investigators: The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol. 2004, 93: 1473-1480. 10.1016/j.amjcard.2004.02.058.View ArticlePubMedGoogle Scholar
- Primatesta P, Bost L, Poulter NR: Blood pressure levels and hypertension status among ethnic groups in England. J Hum Hypertens. 2000, 14: 143-148. 10.1038/sj.jhh.1000960.View ArticlePubMedGoogle Scholar
- Cruickshank JK, Jackson SH, Bannan LT, Beevers DG, Beevers M, Osbourne VL: Blood pressure in black, white and Asian factory workers in Birmingham. Postgrad Med J. 1983, 59: 622-626.View ArticlePubMedPubMed CentralGoogle Scholar
- Lane D, Beevers DG, Lip GYH: Ethnic differences in blood pressure and prevalence of hypertension in England. J Hum Hypertens. 2002, 16: 267-273. 10.1038/sj.jhh.1001371.View ArticlePubMedGoogle Scholar
- Cappuccio FP, Cook DG, Atkinson RW, Wicks PD: The Wandsworth Heart and Stroke Study. A population-based survey of cardiovascular risk factors in different ethnic groups. Methods and baseline findings. Nutr Metab Cardiovasc Dis. 1998, 8: 371-385.Google Scholar
- Chaturvedi N, McKeigue PM, Marmot MG: Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension. 1993, 22: 90-96.View ArticlePubMedGoogle Scholar
- Agyemang C, Bhopal R: Is the blood pressure of people from African origin adults in the UK higher or lower than that in European origin white people? A review of cross-sectioned data. J Human Hypertens. 2003, 17: 523-534. 10.1038/sj.jhh.1001586.View ArticleGoogle Scholar
- Ordunez-Garcia PO, Espinosa-Brito AD, Cooper RS, Kaufman JS, Nieto FJ: Hypertension in Cuba: Evidence of a narrow black-white difference. J Human Hypertens. 1998, 12: 111-116. 10.1038/sj.jhh.1000562.View ArticleGoogle Scholar
- Miller GJ, Maude GH, Beckles GL: Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiol Community Health. 1996, 50: 497-504.View ArticlePubMedPubMed CentralGoogle Scholar
- James SA, de Almeida-Filho N, Kaufman JS: Hypertension in Brazil: a review of the epidemiological evidence. Ethn Dis. 1991, 1: 91-98.PubMedGoogle Scholar
- Rywik SL, Davis CE, Pajak A, Broda G, Folsom AR, Kawalec E, Williams OD: Poland and U.S. Collaborative Study on Cardiovascular Epidemiology. Hypertension in the community: Prevalence, awareness, treatment, and control of hypertension in the Pol-MONICA Project and the U.S. Atherosclerosis Risk in Communities study. Ann Epidemiol. 1998, 8: 3-13. 10.1016/S1047-2797(97)00177-4.View ArticlePubMedGoogle Scholar
- Strasser T: Hypertension: The East European experience. Am J Hypertens. 1998, 11: 756-758. 10.1016/S0895-7061(98)00070-3.View ArticlePubMedGoogle Scholar
- Tyroler HA, Gasunov IS, Deev AD: A comparison of high blood pressure prevalence and treatment status in selected US and USSR populations. First Joint US-USSR Symposium on Hypertension. 1979, Bethesda, Md: NIH DHEW publication 79-1272, Bethesda, MDGoogle Scholar
- Kaufman J, Cooper RS: Seeking causal explanations in social epidemiology. Am J Epidemiol. 1999, 150: 113-120.View ArticlePubMedGoogle Scholar
- Cooper RS, Kaufman JS: Race and hypertension: Science or nescience?. Hypertension. 1998, 32: 813-816.View ArticlePubMedGoogle Scholar
- Mountain JL, Risch N: Assessing genetic contributions to phenotypic differences among 'racial' and 'ethnic' groups. Nat Genet. 2004, 36 (11 Suppl): S48-53. 10.1038/ng1456.View ArticlePubMedGoogle Scholar
- Kaufman JS, Cooper RS, McGee D: Socioeconomic status and health in blacks and whites: The problem of residual confounding and the resiliency of race. Epidemiology. 1997, 8: 621-628. 10.1097/00001648-199710000-00002.PubMedGoogle Scholar
- Cooper RS, Kaufman J, Ward R: Race and genomics. N Engl J Med. 2003, 348: 1166-1170. 10.1056/NEJMsb022863.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1741-7015/3/2/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.